Effect of Acute Metabolic Stress on Pituitary-Adrenal Axis Activation in Patients With Schizophrenia

OBJECTIVE: Although several lines of evidence suggest that stress plays a role in the course of schizophrenia, studies that have assessed stress-relevant neurobiological measures have not produced consistent results. The authors examined the effects of acute metabolic stress induced by 2-deoxy-D-glucose (2-DG) on pituitary-adrenal axis activation. METHOD: Thirteen patients with schizophrenia and 11 healthy comparison subjects were administered pharmacological doses of 2-DG (40 mg/kg). The subjects' arterial plasma was then assayed for levels of adrenocorticotropic hormone (ACTH) and cortisol. RESULTS: 2-DG induced significant increases in the measured hormones in both groups, and ACTH elevations were significantly greater in patients with schizophrenia than in comparison subjects. CONCLUSIONS: Patients with schizophrenia have an exaggerated ACTH response to acute metabolic stress exposure. (Am J Psychiatry 1998; 155:979–981)

[1]  I. Elman,et al.  Effects of acute metabolic stress on plasma progesterone and testosterone in male subjects: relationship to pituitary-adrenocortical axis activation. , 1997, Life sciences.

[2]  A. Ohman,et al.  Relationships between social support, social coping and life events in the relapse of schizophrenic patients. , 1997, Scandinavian journal of psychology.

[3]  I. Heuser,et al.  Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II , 1995, Biological Psychiatry.

[4]  R. Flannery,et al.  Stress management for psychiatric patients in a state hospital setting. , 1995, The American journal of orthopsychiatry.

[5]  David S. Goldstein,et al.  Stress, Catecholamines, and Cardiovascular Disease , 1995 .

[6]  P. Hindmarsh,et al.  Reproducibility of the cortisol response to stimulation with a low dose of ACTH(1-24): the effect of basal cortisol levels and comparison of low-dose with high-dose secretory dynamics. , 1993, The Journal of endocrinology.

[7]  O. Wolkowitz,et al.  Benzodiazepines in the treatment of schizophrenia: a review and reappraisal. , 1991, The American journal of psychiatry.

[8]  R. Tandon,et al.  Dexamethasone suppression test in schizophrenia: Relationship to symptomatology, ventricular enlargement, and outcome , 1991, Biological Psychiatry.

[9]  V. Yeragani.  The Incidence of Abnormal Dexamethasone Suppression in Schizophrenia: A Review and a Meta-Analytic Comparison with the Incidence in Normal Controls , 1990, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[10]  A. Breier.  Experimental approaches to human stress research: Assessment of neurobiological mechanisms of stress in volunteers and psychiatric patients , 1989, Biological Psychiatry.

[11]  O. Wolkowitz,et al.  Neurobiological effects of lumbar puncture stress in psychiatric patients and healthy volunteers , 1988, Psychiatry Research.

[12]  J. Meador-Woodruff,et al.  Effects of psychotropic medications on hypothalamic-pituitary-adrenal regulation. , 1988, Endocrinology and metabolism clinics of North America.

[13]  J. Eisenberg,et al.  Dexamethasone suppression test in schizophrenia. A study and review. , 1986, Neuropsychobiology.

[14]  V. Fang,et al.  Physiological dosing of exogenous ACTH. , 1985, Acta endocrinologica.

[15]  M. Baron,et al.  Stressful life events and schizophrenia. Relation to illness onset and family history. , 1984, Neuropsychobiology.

[16]  C. McMartin,et al.  Fate of human corticotrophin immediately after intravenous administration to the rat. , 1982, The Journal of endocrinology.

[17]  M. Ackenheil,et al.  Experimental stress situations and the state of autonomic arousal in schizophrenic and depressive patients. , 1982, International pharmacopsychiatry.

[18]  B. Meldrum,et al.  ENZYMIC AND CEREBRAL METABOLIC EFFECTS OF 2‐DEOXY‐d‐GLUCOSE , 1973, Journal of neurochemistry.